Coming Soon!  ASCP Psychopharmacology Update: State-of-the-Art Fall Meeting

October 7- 8, 2023 | New York, NY

Recordings: The recordings are available until Wednesday, November 16th and can only be accessed by those that registered for the meeting. To access, CLICK HERE to login to your ASCP account and click the hyperlink of each session you want to access.

Evaluation: Please complete your evaluation by Wednesday, November 16, 2022. The CME Committee strives to continue to improve the meeting. The evaluation is anonymous, please log out of the meeting website to start your evaluation.

CME Request: In order to receive your CME credits, you must complete the evaluation. After completing the evaluation, you will be prompted to log in to your ASCP account, where you will attest the sessions you attended. Please complete your CME Request by Wednesday, November 16, 2022.

All certificates will be emailed to you upon completion of your evaluation and education hours. 

Information about CME Credit
The American Society of Clinical Psychopharmacology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The American Society of Clinical Psychopharmacology takes responsibility for the content, quality and scientific integrity of this CME Activity.

In 2022, the Society designates this live internet course for a maximum of 18 AMA PRA Category 1 Credit(s)TM. Each physician should claim only those hours of credit that (s)he actually spent in the educational activity.

Self-Assessment Maintenance of Certification Program
The American Board of Psychiatry and Neurology has reviewed the 2022 Psychopharmacology: State-Of-The-Art Fall Meeting and has approved this program as part of a comprehensive self-assessment program, which is mandated by the ABMS as a necessary component of maintenance of certification.

Regarded as one of the best clinical update meetings in the field, the program is designed to provide state-of-the-art education on new developments in psychopharmacology for psychiatrists and other professionals already knowledgeable about the pharmacologic treatment of psychiatric disorders.  The goal is to have the participants better assess patients in need of psychopharmacologic intervention and properly administer state-of-the-art treatment.

 2022 Topics and Presenters Included:

Autism and Developmental Disabilities Robert Christian, M.D.
Transdiagnostic Approach to Impulse Control Emil Coccaro, M.D.
Pharmacotherapy of Early Onset Bipolar Disorder Melissa DelBello, M.D.
Anti-inflammatories as Antidepressants Ishrat Husain, M.D. (Res.)
New Research in Schizophrenia Treatments John Kane, M.D.
Treatment of Refractory Depression Matthew Macaluso, D.O.
Tips and Tricks for Managing Adverse Psychiatric Drug Effects Rajnish Mago, M.D.
Is NMDA Receptor Blockade A Class Antidepressant Effect? James Murrough, M.D., Ph.D.
Exploring New Treatments In Agitation Sheldon Preskorn, M.D.
Eating Disorders (Anorexia and Bulimia and pharmacological treatments Tim Walsh, M.D.
What Meta-Analyses Teach Us About Choosing the Best Pharmacotherapies for Bipolar Disorder Michele Fornaro, M.D., Ph.D.
Stigma and Psychopharmacology: Strategies to Advance Racial Equity in Treatment Aderonke Bamgbose Pederson, M.D.



  • 2022: Virtual Meeting, October 15-16, 2022.
  • 2021: Virtual Meeting, October 16-17, 2021.
  • 2020: Virtual Meeting, October 17-18, 2020.
  • 2019: The Roosevelt Hotel New York, October 26-27, 2019.
  • 2018: The Roosevelt Hotel New York, October 6-7, 2018.
  • 2017: The Roosevelt Hotel New York, October 21-22, 2017.
  • 2016: Grand Hyatt New York, October 29-30, 2016.
  • 2015: Grand Hyatt New York, October 4-5, 2015.
  • 2014: Grant Hyatt New York, October 11-2, 2014.